CellEctric is building the bridge between electrodynamics and biology. We believe that electrodynamic cell manipulation will make routine life science applications faster, easier, and more precise. By combining cutting-edge developments in material science, electrical engineering, and biotechnology, CellEctric is committed to shaping a better, healthier future for all. Founded in early 2021, we are currently developing a platform that transforms complex samples into simple, single-population solutions. Our current showcase is the isolation of viable bacteria from human samples toward greatly accelerated sepsis diagnosis. The future pipeline is filled with proof-of-concept applications such as the isolation of leukocytes from human whole blood, toward a customizable platform that separates increasingly similar mammalian cell populations at high throughput.